FDA Approves Alcon’s AcrySof(R) IQ ReSTOR(R) +3.0 D Intraocular Lens

Asides

• WASHINGTON - A Senate Finance Committee report released last week that outlines options for financing healthcare reform names HME reimbursement as a possible revenue source, but it doesn't propose specific cuts.

  via Cuts to HME: Reform report leaves door 'wide open' - HME News | The Business Newspaper for Home Medical Equipment Providers.

  - #

• Prefilled syringes are replacing vials both in terms of injections and sector revenue, and as this trend continues during the next 4 years, the number of tailored injectable drug products reaching the market is set to escalate.

  via Prefilled syringes proving popular - Pharm Tech Europe.

  - #

• the investigators reported an anterior shift of less than 0.5 D of accommodation, which was disappointing in that patients were not spectacle-independent, according to Eduardo Marques, MD

  via Accommodative lens results considered 'disappointing' - IOL shifts forward but offers less than 0.5 D of pseudophakic accommodation - Modern Medicine.

  - #

• FDA Approves Alcon's AcrySof(R) IQ ReSTOR(R) +3.0 D Intraocular Lens in the US. The product is already sold in Europe.

  New Lens Corrects for Cataracts with Presbyopia

  - #

• Advanced Medical Optics (AMO), Inc. and FDA notified healthcare professionals of a recall of Healon D Ophthalmic Viscosurgical Device, Lot Number UD30654, 30 mg/mL fill size syringes. Some of the tested OVD syringes had endotoxin levels above the required limit.

  - #